Grifols creates the Board of Directors' Strategy Committee

Barcelona, Spain, September 29, 2025 – Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leader in plasma-derived medicines, today announced the creation of a Strategy Committee within its Board of Directors. The new committee will ensure that the Board maintains a long-term perspective whilst supporting Management’s continued execution of its medium-term Capital Markets Day Plan and thereby safeguarding Grifols’ successful track record of strategic growth over the past few decades and positioning the company to sustain success in the future.

The Strategy Committee will provide a framework for shaping Grifols’ strategic policies, aligning Management with the long-term interests of shareholders and shareholder value creation while supporting Management with critical expertise where needed to continue advancing in the plasma industry.

The new committee will be composed of five non-executive directors with proven expertise in strategy, regulation, and in-depth knowledge of the plasma business on a global scale. It will be chaired by the company's non-executive chair and independent director, Ms. Anne-Catherine Berner, in line with the recommendations of the CNMV's Code of Good Corporate Governance. The new body will also be composed of proprietary directors Raimon Grifols Roura and Víctor Grifols Deu, external director Tomás Dagá Gelabert, and independent director Íñigo Sánchez-Asiaín Mardones. The new committee will thus combine the vision of the independent directors with the long-term approach, deep industry knowledge, and experience of the founding family, providing a balanced perspective that combines stability, innovation, and strategic direction.

International best practice in corporate governance recognizes the value of specialized committees in enhancing the quality of the Board of Directors' strategic analysis. The new Strategy Committee also reinforces compliance with the Spanish Companies Law, which assigns the Board direct responsibility for the company's strategy.

Grifols' current position as a global leader is the result of a consistent long-term vision built on innovation, stability, and profound industry expertise. The creation of the Strategy Committee reflects the company’s commitment to sustaining this vision while consolidating a governance model that is rigorous and prepared for the future.